Cooper Companies Inc. logo

Cooper Companies Inc. (C1OO34)

Market Closed
10 Aug, 19:55
B3 B3
R$
38. 60
+1.2
+3.2086%
R$
72.94B Market Cap
64.05 P/E Ratio
0.01% Div Yield
26 Volume
3.55 Eps
R$ 37.4
Previous Close
Add Transaction
Day Range
38.6 38.6
Year Range
29 47
Want to track C1OO34 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

C1OO34 closed today higher at R$38.6, an increase of 3.2086% from yesterday's close, completing a monthly increase of 10.6651% or R$3.72. Over the past 12 months, C1OO34 stock lost -16.1781%.
C1OO34 is not paying dividends to its shareholders.
The last earnings report, released on May 27, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Cooper Companies Inc. has completed 1 stock splits, with the recent split occurring on Feb 20, 2024.
The company's stock is traded on one exchange.

C1OO34 Chart

People also search for

STMicroelectronics N.V.
R$ 285.36
+0.6561%
Costar Group Inc.
R$ 1.58
0%
Baidu Inc. BDR
R$ 39.92
+0.4024%
Twilio Inc.
R$ 51.41
+4.0899%
Ericsson (L.M.) Telephone Co. - ADR
R$ 25.77
+4.332%

Cooper Companies Inc. (C1OO34) FAQ

What is the stock price today?

The current price is R$38.60.

On which exchange is it traded?

Cooper Companies Inc. is listed on B3.

What is its stock symbol?

The ticker symbol is C1OO34.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.01%.

What is its market cap?

As of today, the market cap is 72.94B.

Has Cooper Companies Inc. ever had a stock split?

Cooper Companies Inc. had 1 splits and the recent split was on Feb 20, 2024.

Cooper Companies Inc. Profile

Electronic Equipment, Instruments & Components Industry
Information Technology Sector
Mr. Albert G. White III CEO
B3 Exchange
- ISIN
BR Country
15,000 Employees
- Last Dividend
21 Feb 2024 Last Split
30 Dec 1983 IPO Date

Overview

The Cooper Companies, Inc., established in 1958 and headquartered in San Ramon, California, is a global corporation dedicated to fulfilling the needs of contact lens wearers and supporting women's health care through its two primary divisions: CooperVision and CooperSurgical. CooperVision specializes in the development, manufacture, and market of a wide range of contact lenses to correct various visual impairments including nearsightedness, farsightedness, astigmatism, and presbyopia across regions such as the Americas, Europe, Middle East, Africa, and Asia Pacific. On the other hand, CooperSurgical focuses on delivering comprehensive solutions in family and women's healthcare by offering an extensive range of products and services that cover fertility, contraception, surgical procedures, and cryostorage for cord blood and tissue, catering to health care professionals and patients globally. The company's relentless commitment to quality, innovation, and accessibility has enabled it to establish a dominant presence in the eye care and women's health markets worldwide.

Products and Services

  • CooperVision Contact Lenses:

    Delivers an extensive portfolio of spherical, toric, and multifocal lenses designed to address various vision challenges such as nearsightedness, farsightedness, astigmatism, and presbyopia. Among its innovative products, it offers silicone hydrogel lenses that combine comfort with oxygen permeability, enhancing the wearing experience for users.

  • CooperSurgical Women's Health Care:

    Focused on advancing family and women's health, CooperSurgical offers a broad range of products including but not limited to fertility solutions, medical devices for surgical procedures, and non-surgical office-based interventions. Key products include Paragard—a non-hormonal IUD, fertility consumables and equipment, endosee endometrial imaging systems, Mara Water Ablation System for the treatment of heavy menstrual bleeding, and various fertility-assisting technologies like donor gamete services and genomic services involving genetic testing.

  • Cryostorage Services:

    Through CooperSurgical, the company also provides cryopreservation services for cord blood and cord tissue. This service offers families the opportunity to store stem cells that could be used in future medical treatments, highlighting Cooper's commitment to supporting health throughout all stages of life.

  • Endosee Endometrial Imaging and Surgical Devices:

    These include a range of products designed for the diagnosis and treatment of various gynecological conditions, such as the Endosee handheld hysteroscopy system which allows for direct visualization of the endometrial cavity at the point-of-care without the need for anesthesia.

  • Fetal Pillow Cephalic Elevation Device:

    A specialized device used in cesarean sections to assist with the safe delivery of the baby, exemplifying Cooper's innovation in enhancing clinical outcomes for mothers and their newborns.

Contact Information

Address: 6101 Bollinger Canyon Road, San Ramon, CA, United States, 94583
Phone: 925 460 3600